FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to virus inactivation in donor enzyme ceruloplasmin production. The disclosed method involves chromatographic purification of enzyme solution by washing with acetate buffer thereafter followed with elution. The enzyme solution is prepared with a solvent-detergent mixture and pre-washed in two stages while being immobilised on sulphopropylcation sorbent. And the first stage includes application of acetate buffer containing sodium caprilate, sodium chloride and propylene glycol, while the second stage involves acetate buffer containing sodium chloride.
EFFECT: invention provides high effectiveness in virus removing and inactivation thereby improving virus safety ceruloplasmin.
9 cl, 6 ex
Title | Year | Author | Number |
---|---|---|---|
CERULOPLASMIN RECOVERY METHOD | 2007 |
|
RU2356560C1 |
METHOD OF VIRUS INACTIVATION FOR IMMUNOGLOBULIN PRODUCTION | 2007 |
|
RU2372940C2 |
METHOD FOR PRODUCING IMMUNOGLOBULIN | 2007 |
|
RU2372939C2 |
METHOD FOR CHROMATOGRAPHIC EXTRACTION OF IMMUNOGLOBULIN | 2010 |
|
RU2467783C2 |
METHOD FOR MAKING CERULOPLASMIN | 2008 |
|
RU2372097C1 |
METHOD FOR CHROMATOGRAPHIC EXTRACTION AND PURIFICATION OF IMMUNOGLOBULINS | 2018 |
|
RU2694620C1 |
METHOD OF IMMUNOGLOBULIN PURIFICATION (VERSIONS) | 2007 |
|
RU2332247C1 |
METHOD OF PRODUCING THROMBIN CONCENTRATE | 2014 |
|
RU2583931C2 |
METHOD OF PREPARATION OF VIRUS-INACTIVATED SOLUTIONS OF IMMUNOGLOBULINS | 2007 |
|
RU2352358C1 |
PLASMID VECTOR PRH15A FOR PRODUCING METHIONINE-FREE INTERFERON ALPHA-2B, BACTERIAL STRAIN ESCHERICHIA COLI BL21 DE3 - PRODUCER OF METHIONINE-FREE INTERFERON ALPHA-2B AND METHOD FOR PRODUCING METHIONINE-FREE INTERFERON ALPHA-2B | 2017 |
|
RU2697375C2 |
Authors
Dates
2009-05-27—Published
2007-12-17—Filed